Provided by Tiger Trade Technology Pte. Ltd.

Defiance Daily Target 2X Long MRNA ETF

183.82
+39.8127.64%
Post-market: 176.67-7.1527-3.89%19:59 EDT
Volume:505.18K
Turnover:85.97M
Market Cap:55.15M
PE:- -
High:183.82
Open:145.71
Low:144.11
Close:144.01
52wk High:183.82
52wk Low:14.95
Shares:300.00K
Float Shares:300.00K
Volume Ratio:2.12
T/O Rate:168.39%
Dividend:- -
Dividend Rate:- -
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Moderna Has Surged 660% Year-To-Date, Joining The Nasdaq 100 As BofA Raises Its Price Target

Reuters
·
Oct 10

24H | IREN Rises Nearly 7%; CRCL, BMNR Gain 2.7%; SOXL Advances 2%

US Overnight
·
47 mins ago

Weekly Winners | PTC Soars Over 35%; Moderna Hits New High in More Than Four Years; Energy and SpaceX Partnership Concepts Show Strong Momentum

Tiger Newspress
·
Oct 10

Post-Bell|U.S. Indices Rise; Moderna Surges Over 14%, Palantir Jumps More Than 5% to a Record High, Tesla Rises Over 2%

Tiger Newspress
·
Oct 10

Moderna Inc. Stock Advances 14.2%, Outperforms Peers

Dow Jones
·
Oct 10

ETF Daily | MRNX Soars 28%; ASTN Jumps 22%; YINN Advances 7%; Healthcare and China Beta Lead

ETF Tracker
·
Oct 10

S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT

Reuters
·
Oct 10

Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why

TIPRANKS
·
Oct 10

Moderna up over 11%, on Track for Highest Close Since January 2022

Dow Jones
·
Oct 10

Sector Update: Healthcare

MT Newswires Live
·
Oct 10

Flu Season is Already Here. Here's What to Know About This Year's Flu Shots.

Dow Jones
·
Oct 10

Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors

TIPRANKS
·
Oct 10

Retension Pharmaceuticals Debuts on US Stock Market, Shares Drop Over 10% After Opening

Stock News
·
Oct 10

Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand

MT Newswires Live
·
Oct 10

Top Midday Gainers

MT Newswires Live
·
Oct 10

Moderna Stock Surges Over 10% to Hit New Recent High: Melanoma Vaccine Data Set for ESMO, BofA Raises Price Target to $200

TradingKey
·
Oct 09

NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-10-09

Reuters
·
Oct 09

Market Chatter: Moderna, Other Vaccine Developer Stocks Rise as NIH Plans to Expedite Cancer Vaccines

MT Newswires Live
·
Oct 09

NIH Plans to Expedite Cancer Vaccines, NYT Reports; Vaccine Developer Shares Jump

MT Newswires Live
·
Oct 09

Pharma Stocks Jump With Novavax up 12%, Moderna up 6%

Tiger Newspress
·
Oct 09